Glenn Pogust, Special Counsel in the Complex Commercial Litigation Department and member of the Product Liability Group, focuses his practice on the defense of manufacturers of a wide variety of products in personal injury and property damage cases, as well as cases involving product performance or malfunction claims that do not involve injury.
Glenn has been involved in all phases of litigation at the trial and appellate levels and in the federal and state courts in New York, as well as in jurisdictions throughout the country. Glenn has been consistently recognized as a leader in New York Mass Tort Litigation/Class Actions and in Product Liability Defense by The Best Lawyers in America.
Glenn’s extensive experience includes the representation of major pharmaceutical companies, and the defense of chemical, paint product and adhesive manufacturers with respect to a wide range of claimed injuries including chronic disease, wrongful death, and burn injuries from explosions and fires. In addition, Glenn has represented manufacturers of industrial machinery, power tools, glass products, drug products, medical devices and consumer products. He has experience in aviation and asbestos litigation and has litigated a variety of commercial, construction and employment disputes. Recently, Glenn has been active in the food, beverage & supplements space, and has published a number of articles in the emerging area of food liability.
Glenn is also frequently asked to provide advice and risk assessments on non-litigated matters, including reviews of labeling, manuals and operating procedures for new or existing products, due diligence reviews relating to corporate and finance transactions, drafting or revising contract language to protect clients from potential post-transaction liability exposure, and assisting with the resolution of claims that are not yet in litigation.
Glenn is actively involved in the firm’s pro bono program and serves as co-head of the Immigration Practice Group. He also serves on the Board of Trustees of Kimball Union Academy.
- Lead counsel for AstraZeneca in all state court cases involving the atypical antipsychotic medication Seroquel, including coordination of pre-trial proceedings in Delaware, New Jersey, New York, California and Missouri.
- Obtained summary judgment and successfully argued the appeal of a claim that a major coatings company negligently misrepresented the performance capabilities of one of its products.
- Served as a key member of the national defense team in litigation involving over-the-counter decongestants, including acting as lead counsel for all New York cases and acting as settlement counsel to resolve the litigation in its entirety.
- Lead defense counsel in the MDL and New York courts in the Rezulin litigation.
- Regional and local counsel for three phentermine manufacturers in the Fen-Phen litigation.
- Obtained summary judgment for PPG Industries, Inc., The Dow Chemical Company, Ethyl Corp. and another bulk chemical supplier, and successfully argued the appeal of a claim alleging groundwater contamination of an industrial site.
- Regional, local and trial counsel for Dow Chemical Co. on the silicone breast implant litigation.
- Obtained summary judgment for a major industrial machine manufacturer in a case involving catastrophic personal injury.
- Obtained the reversal on appeal of an multi-million dollar verdict involving exposure to chlorinated solvents.
- National coordinating counsel and trial team member for International Playtex in the toxic shock syndrome litigation.
In The Market
- Kaye Scholer Represents American Securities in Milk Specialties Acquisition June 28, 2016 • Pressemitteilungen
- Kaye Scholer Represents J.W. Childs in Investment in Comoto Holdings Inc. March 17, 2016 • Pressemitteilungen
- Kaye Scholer Represents Fremont in Equity Investment in Process Displays January 22, 2016 • Pressemitteilungen